Clinical Trial Consultants AB   Report issue

For profit Phase 1 Phase 2
Founded: Uppsala Sweden (2011)

Organization Overview

First Clinical Trial
2012
NCT02524262
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Clinical Trial Consultants AB | Clinical Trial Consultants, CTC | Clinical Trial Consultants, Uppsala, Sweden | CTC Clinical Trial Consultants | CTC Clinical Trial Consultants AB | CTC Clinical Trial Consultants AB,Dag Hammarskjolds v- 10B, SE-752 37 Uppsala, Sweden

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Body Weight (Phase 2)

Breast Neoplasms (Phase 1)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Gastritis (Phase 2)

Gastritis, Atrophic (Phase 2)

Overweight (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 25
  • # of Trial APIs: 28